- cafead   Mar 24, 2024 at 10:32: PM
via The U.S. Food and Drug Administration said on Friday it had granted traditional approval for AbbVie's (ABBV.N) "guided missile" cancer therapy, Elahere, for patients with a type of ovarian cancer.
article source
article source